Evidence map›Paper›PMID 34745621›Full record

ArticleClinical case reports2021

Mucormycosis infection in severe COVID-19 patient with multiple underlying health conditions.

Zahra Heydarifard, Moslem Safaei, Sevrin Zadheidar, Soroush Ehsan, Nazanin Zahra Shafiei-Jandaghi

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Zahra HeydarifardVirology Department School of Public Health Tehran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0002-2093-819X
Moslem SafaeiDepartment of Pharmacy School of Pharmacy Shahid Sadoughi University of Medical Science Yazd Iran.
Sevrin ZadheidarVirology Department School of Public Health Tehran University of Medical Sciences Tehran Iran.
Soroush EhsanDepartment of Neurology Valiasr Naja Hospital Shahid Beheshti University of Medical Sciences Tehran Iran.
Nazanin Zahra Shafiei-JandaghiVirology Department School of Public Health Tehran University of Medical Sciences Tehran Iran.
Tehran University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRShahid Sadoughi University of Medical Sciences and Health Services · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID-19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID-19 and mucormycosis.

Indexed as

mucormycosisSARS‐CoV‐2severe COVID‐19underlying health conditions

Identifiers

PMID34745621
PMCPMC8552078
OpenAlexW3185205023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.